Cubresa Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 14
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 4

Cubresa General Information

Description

Designer and developer of clinical and preclinical PET inserts for MRI. The company provides planar gamma and SPECT imaging services for the diagnostic, surgical and pre-clinical imaging marketplace, enabling medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.

Contact Information

Website
www.cubresa.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 11 – 1393 Border Street
  • Winnipeg, Manitoba R3H 0N1
  • Canada
+1 (204) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cubresa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 00000 Completed Startup
1. Angel (individual) 01-Jul-2013 00000 00000 Completed Startup
To view Cubresa’s complete valuation and funding history, request access »

Cubresa Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Designer and developer of clinical and preclinical PET inserts for MRI. The company provides planar gamma and SPECT imag
Diagnostic Equipment
Winnipeg, Canada
14 As of 2016
00000
000000000000 00000

00000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et do
0000000000 000000000
Warwick, United Kingdom
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cubresa Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 0000000 Formerly PE-Backed Warwick, United Kingdom 000 000000&0
You’re viewing 1 of 1 competitors. Get the full list »

Cubresa Executive Team (7)

Name Title Board Seat Contact Info
James Schellenberg Ph.D Founder, Chief Executive Officer & Board of Director
Bob Schellenberg General Manager- Preclinical Division, Chief Operating Officer & Board Member
John Saunders Chief Science Officer & Board of Director
Cheryl Dika Medical Consultant
You’re viewing 4 of 7 executive team members. Get the full list »

Cubresa Board Members (5)

Name Representing Role Since
Bob Schellenberg Cubresa General Manager- Preclinical Division, Chief Operating Officer & Board Member 000 0000
David Asper Self Board Member 000 0000
Gene Dunn Self Board Member 000 0000
John Saunders Cubresa Chief Science Officer & Board of Director 000 0000
Ron Sabourin Self Board Member 000 0000
To view Cubresa’s complete board members history, request access »

Cubresa Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cubresa Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kevin D'Silva Angel (individual) Minority 000 0000 000000 0
Manitoba Knights Corporation Minority 000 0000 000000 0
Manitoba Technology Accelerator Accelerator/Incubator 000 0000 000000 0
Canadian Technology Accelerator Accelerator/Incubator 000 0000 000000 0
To view Cubresa’s complete investors history, request access »